<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01059357</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00009802</org_study_id>
    <secondary_id>CCCWFU 60209</secondary_id>
    <nct_id>NCT01059357</nct_id>
  </id_info>
  <brief_title>Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System</brief_title>
  <acronym>TORS</acronym>
  <official_title>A Pilot Study Assessing Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Benign and Malignant Lesions Using the Da Vinci Robotic Surgical System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to conduct a pilot single-arm to assess transoral robotic
      surgery (TORS) for oral and laryngopharyngeal benign and malignant lesions using the Da Vinci
      Robotic Surgical System.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients are going to be evaluated in their usual regular clinical follow ups starting with
      preoperative first visit, 3 weeks, 3 months and 6 months postoperatively with a Quality of
      Life survey (Head and Neck Cancer Inventory, HNCI-QOLQ).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2010</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Number and Percent of All Evaluable Patients Who Have Successfully Undergone TORS at Each Interim Analysis.</measure>
    <time_frame>At time of surgery, lasting up to 3 hours. Assessed for up to 6 months</time_frame>
    <description>In order to evaluate the feasibility of TORS, the investigators will report the number and percent of all evaluable patients who have successfully undergone TORS at each interim analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative Time</measure>
    <time_frame>At time of surgery, up to 3 hours</time_frame>
    <description>The total operative times include the induction of and emergence from anesthesia, the TORS procedure, plus any adjunct procedures (eg, neck dissections) performed during the same operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Blood Loss and Complications</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Time to Set up and Perform Procedures</measure>
    <time_frame>At time of surgery, up to 3 hours</time_frame>
    <description>This outcome is to identify the learning curve for TORS by measuring the efficiency of the surgeon who performs the procedures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Correctly Predicted Success of TORS Preoperatively</measure>
    <time_frame>preoperative</time_frame>
    <description>This outcome is to identify the learning curve for TORS by measuring the accuracy of the surgeon who performs the procedures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QOL</measure>
    <time_frame>6 months</time_frame>
    <description>Quality of life (QOL) of the patients undergoing TORS will be measures. The score range is 0-100 with higher scores denoting better outcome.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Head and Neck Neoplasms</condition>
  <arm_group>
    <arm_group_label>Transoral Robotic Surgery (TORS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transoral Robotic Surgery (TORS) using the Da Vinci Robotic Surgical System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Da Vinci Robotic Transoral Robotic Surgical System</intervention_name>
    <description>(TORS) Da Vinci Robotic Transoral Robotic Surgical System</description>
    <arm_group_label>Transoral Robotic Surgery (TORS)</arm_group_label>
    <other_name>(TORS) Da Vinci Robotic Transoral Robotic Surgical System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient must present with indications for diagnostic or therapeutic approaches for
             benign and malignant diseases of the oral cavity or laryngopharynx (including the
             neoplastic lesions of the tongue, tongue base, retromolar trigone, tonsils, palate,
             posterior and lateral pharynx, glottic, supraglottic and subglottic larynx)

          -  Patients must have adequate transoral exposure of the oral cavity and laryngopharynx
             for TORS instrumentation

        Exclusion Criteria:

          -  Unexplained fever and/or untreated, active infection

          -  Patient pregnancy

          -  Previous head and neck surgery precluding transoral/robotic procedures

          -  The presence of medical conditions contraindicating general anesthesia or transoral
             surgical approaches
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joshua D. Waltonen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>January 21, 2010</study_first_submitted>
  <study_first_submitted_qc>January 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2010</study_first_posted>
  <results_first_submitted>September 21, 2018</results_first_submitted>
  <results_first_submitted_qc>November 13, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">November 16, 2018</results_first_posted>
  <last_update_submitted>November 13, 2018</last_update_submitted>
  <last_update_submitted_qc>November 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Transoral Robotic Surgery (TORS)</title>
          <description>Transoral Robotic Surgery (TORS) using the Da Vinci Robotic Surgical System
Da Vinci Robotic Transoral Robotic Surgical System: (TORS) Da Vinci Robotic Transoral Robotic Surgical System</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Transoral Robotic Surgery (TORS)</title>
          <description>Transoral Robotic Surgery (TORS) using the Da Vinci Robotic Surgical System
Da Vinci Robotic Transoral Robotic Surgical System: (TORS) Da Vinci Robotic Transoral Robotic Surgical System</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="58"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.64" lower_limit="27" upper_limit="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Number and Percent of All Evaluable Patients Who Have Successfully Undergone TORS at Each Interim Analysis.</title>
        <description>In order to evaluate the feasibility of TORS, the investigators will report the number and percent of all evaluable patients who have successfully undergone TORS at each interim analysis</description>
        <time_frame>At time of surgery, lasting up to 3 hours. Assessed for up to 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Transoral Robotic Surgery (TORS)</title>
            <description>Transoral Robotic Surgery (TORS) using the Da Vinci Robotic Surgical System
Da Vinci Robotic Transoral Robotic Surgical System: (TORS) Da Vinci Robotic Transoral Robotic Surgical System</description>
          </group>
        </group_list>
        <measure>
          <title>The Number and Percent of All Evaluable Patients Who Have Successfully Undergone TORS at Each Interim Analysis.</title>
          <description>In order to evaluate the feasibility of TORS, the investigators will report the number and percent of all evaluable patients who have successfully undergone TORS at each interim analysis</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Operative Time</title>
        <description>The total operative times include the induction of and emergence from anesthesia, the TORS procedure, plus any adjunct procedures (eg, neck dissections) performed during the same operation.</description>
        <time_frame>At time of surgery, up to 3 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Transoral Robotic Surgery (TORS)</title>
            <description>Transoral Robotic Surgery (TORS) using the Da Vinci Robotic Surgical System
Da Vinci Robotic Transoral Robotic Surgical System: (TORS) Da Vinci Robotic Transoral Robotic Surgical System</description>
          </group>
        </group_list>
        <measure>
          <title>Operative Time</title>
          <description>The total operative times include the induction of and emergence from anesthesia, the TORS procedure, plus any adjunct procedures (eg, neck dissections) performed during the same operation.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="321" spread="136.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Blood Loss and Complications</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Transoral Robotic Surgery (TORS)</title>
            <description>Transoral Robotic Surgery (TORS) using the Da Vinci Robotic Surgical System
Da Vinci Robotic Transoral Robotic Surgical System: (TORS) Da Vinci Robotic Transoral Robotic Surgical System</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Blood Loss and Complications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Time to Set up and Perform Procedures</title>
        <description>This outcome is to identify the learning curve for TORS by measuring the efficiency of the surgeon who performs the procedures.</description>
        <time_frame>At time of surgery, up to 3 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Transoral Robotic Surgery (TORS)</title>
            <description>Transoral Robotic Surgery (TORS) using the Da Vinci Robotic Surgical System
Da Vinci Robotic Transoral Robotic Surgical System: (TORS) Da Vinci Robotic Transoral Robotic Surgical System</description>
          </group>
        </group_list>
        <measure>
          <title>Average Time to Set up and Perform Procedures</title>
          <description>This outcome is to identify the learning curve for TORS by measuring the efficiency of the surgeon who performs the procedures.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="109" spread="47.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Correctly Predicted Success of TORS Preoperatively</title>
        <description>This outcome is to identify the learning curve for TORS by measuring the accuracy of the surgeon who performs the procedures.</description>
        <time_frame>preoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Transoral Robotic Surgery (TORS)</title>
            <description>Transoral Robotic Surgery (TORS) using the Da Vinci Robotic Surgical System
Da Vinci Robotic Transoral Robotic Surgical System: (TORS) Da Vinci Robotic Transoral Robotic Surgical System</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Correctly Predicted Success of TORS Preoperatively</title>
          <description>This outcome is to identify the learning curve for TORS by measuring the accuracy of the surgeon who performs the procedures.</description>
          <units>procedures</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>QOL</title>
        <description>Quality of life (QOL) of the patients undergoing TORS will be measures. The score range is 0-100 with higher scores denoting better outcome.</description>
        <time_frame>6 months</time_frame>
        <population>Data not collected on all participants</population>
        <group_list>
          <group group_id="O1">
            <title>Transoral Robotic Surgery (TORS)</title>
            <description>Transoral Robotic Surgery (TORS) using the Da Vinci Robotic Surgical System
Da Vinci Robotic Transoral Robotic Surgical System: (TORS) Da Vinci Robotic Transoral Robotic Surgical System</description>
          </group>
        </group_list>
        <measure>
          <title>QOL</title>
          <description>Quality of life (QOL) of the patients undergoing TORS will be measures. The score range is 0-100 with higher scores denoting better outcome.</description>
          <population>Data not collected on all participants</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52" spread="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>up to 6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Transoral Robotic Surgery (TORS)</title>
          <description>Transoral Robotic Surgery (TORS) using the Da Vinci Robotic Surgical System
Da Vinci Robotic Transoral Robotic Surgical System: (TORS) Da Vinci Robotic Transoral Robotic Surgical System</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Blood loss</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>Postoperative bleeding</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chipped tooth</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Joshua Waltonen</name_or_title>
      <organization>Wake Forest University Health Sciences</organization>
      <phone>3367169068</phone>
      <email>jwaltone@wakehealth.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

